by Colfar | marzo 6, 2019 12:29 pm
Farmacovigilancia.-Tofacitinib-1Source URL: https://colfarsfe.org.ar/2019/03/06/tofacitinib-mayor-riesgo-de-coagulos-sanguineos-pulmonares-y-muerte-a-dosis-altas-en-pacientes-con-artritis-reumatoidea-fda/
Copyright ©2024 Colegio de Farmacéuticos de Santa Fe 1 Circ. unless otherwise noted.